Found: IMH0030 - Men's health Prostate Cancer Research Written Evidence

Found: in public awareness and social media coverage with well-known celebrities and campaigning by PCUK, Prostate

Found: , 2023 iv Men’s Health Forum, Men and cancer: saving lives, 2013 v Prostate Cancer Research, New

Found: Social Tech Trust and Prostate Cancer Research).An interim evaluation of the initial 2017 pilot programme

Found: fi Attitudes Toward Genomic Testing and Prostate Cancer Research Among Black Menfl, American Journal

Found: RFA0075 )60 Photonics Leadership Group ( RFA0041 )61 PraxisAuril ( RFA0084 )62 Prospect ( RFA0055 )63 Prostate

Found: RFA0060 - A new UK research funding agency Prostate Cancer Research Centre

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the press notice entitled Biggest prostate cancer screening trial in decades to start in UK published on 19 November 2023, what assessment her Department has made of the additional workforce capacity that will be required to deliver the trial.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Department funds research through the National Institute for Health and Care Research (NIHR). NIHR invests in the research delivery workforce, the facilities and capacity to support clinical trials. The NIHR Clinical Research Facilities and Experimental Cancer Medicine Centres support the delivery of early phase trials and the NIHR Clinical Research Network and Patient Recruitment Centres support delivery and participation in later phase clinical trials. The prostate cancer trial announced on 19 November will be run by Prostate Cancer UK with the Government contributing alongside others.

To maximise research participation, the NIHR provides the online platform ‘Be Part of Research’, which allows users to search for and register their interest in participating in the clinical trials of most interest and relevance to them. NIHR has also supported initiatives to increase diagnosis rates and participation in prostate cancer research by men from black and minority ethnic groups.

The recently announced TRANSFORM trial aims to save thousands of men each year by finding the best way to screen for prostate cancer. The trial will be United Kingdom-wide, although final decisions on specific locations are yet to be taken. Men will be invited to participate via their general practices. This study will also aim to address some of the inequalities that exist in prostate cancer diagnosis today by ensuring that one in 10 of the trial participants will be black men, who are three times overrepresented compared to the population of men aged 45 to 75 as based on 2021 census data.

The UK National Screening Committee will be reviewing the evidence that is published by this study. This will help to inform any future recommendation on creating a national screening programme for prostate cancer.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the press notice entitled Biggest prostate cancer screening trial in decades to start in UK published on 19 November 2023, in which areas will the trial be carried out; and what steps her Department is taking to (a) ensure there is sufficient diagnostics capacity to deliver the additional screening in the trial areas in local areas to deliver increased screening and (b) encourage participation amongst (i) at-risk groups and (ii) black men.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Department funds research through the National Institute for Health and Care Research (NIHR). NIHR invests in the research delivery workforce, the facilities and capacity to support clinical trials. The NIHR Clinical Research Facilities and Experimental Cancer Medicine Centres support the delivery of early phase trials and the NIHR Clinical Research Network and Patient Recruitment Centres support delivery and participation in later phase clinical trials. The prostate cancer trial announced on 19 November will be run by Prostate Cancer UK with the Government contributing alongside others.

To maximise research participation, the NIHR provides the online platform ‘Be Part of Research’, which allows users to search for and register their interest in participating in the clinical trials of most interest and relevance to them. NIHR has also supported initiatives to increase diagnosis rates and participation in prostate cancer research by men from black and minority ethnic groups.

The recently announced TRANSFORM trial aims to save thousands of men each year by finding the best way to screen for prostate cancer. The trial will be United Kingdom-wide, although final decisions on specific locations are yet to be taken. Men will be invited to participate via their general practices. This study will also aim to address some of the inequalities that exist in prostate cancer diagnosis today by ensuring that one in 10 of the trial participants will be black men, who are three times overrepresented compared to the population of men aged 45 to 75 as based on 2021 census data.

The UK National Screening Committee will be reviewing the evidence that is published by this study. This will help to inform any future recommendation on creating a national screening programme for prostate cancer.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to fund research into new treatment for the most dangerous types of prostate cancers.

Answered by Helen Whately - Minister of State (Department of Health and Social Care)

In 2018, the Government announced £75 million towards clinical trials for prostate cancer, with a focus on improving early diagnosis, survival rates, and exploring options for different treatments for men affected by the disease.

Since April 2018, the National Institute for Health and Care Research (NIHR) has awarded £73.6 million to 45 prostate cancer research programmes.

The NIHR welcomes funding applications for research into any aspect of human health, including prostate cancer. The level of research spend in a particular area, is driven by factors including scientific potential and the number and scale of successful funding applications.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 19 December 2022 to Question 108144 on NHS: Staff, with which (a) trades unions, (b) medical royal colleges, (c) NHS system leaders, (d) voluntary organisations his Department consulted on the NHS workforce plan.

Answered by Will Quince

The following table shows the organisations that have been engaged. This list is not exhaustive because NHS England and Health Education England leaders and programme teams are also working with external stakeholders and their contribution is also informing the plan’s development.

Further discussions will take place before the plan is finalised. This will include engagement with patient representative groups. NHS England can discuss with any organisations interested in the development of the Plan.

Found: Jeremy Hunt 17/10/2023 Soho House; Prostate Cancer Research To discuss the Daily Mail campaign ‘End Needless

Found: Goldsmiths’ Company, a member of the Fabric Commission of Westminster Abbey and former chairman of the Prostate

Found: robotic cystectomy (CORAL) which changed Department of Health polic y Academic -21: Chair, Prostate